Inhibition of FGFR2 enhances chemosensitivity to gemcitabine in cholangiocarcinoma through the AKT/mTOR and EMT signaling pathways

Autor: Jaidee, Rattanaporn, Kukongviriyapan, Veerapol, Senggunprai, Laddawan, Prawan, Auemduan, Jusakul, Apinya, Laphanuwat, Phatthamon, Kongpetch, Sarinya
Zdroj: In Life Sciences 1 May 2022 296
Databáze: ScienceDirect